Crypto Briefing·
Novartis CEO says AI could cut drug development time to eight years

AI's integration in pharma could revolutionize drug development, enhancing efficiency and success rates, but regulatory and policy challenges remain.
Every crypto headline. One feed. Updated every minute.

AI's integration in pharma could revolutionize drug development, enhancing efficiency and success rates, but regulatory and policy challenges remain.